Effect of Androgen Deprivation Therapy on the Expression of Prostate Cancer Biomarkers MSMB and MSMB-binding Protein CRISP3

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/pcan.2010.25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Promoter Variants in the MSMB Gene Associated With Prostate Cancer Regulate MSMB/NCOA4 Fusion Transcripts

Human Genetics
Genetics
2012English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Androgen Deprivation Therapy as Backbone Therapy in the Management of Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Androgen Deprivation Therapy in Nonmetastatic Prostate Cancer Patients: Indications, Treatment Effects, and New Predictive Biomarkers

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Evolving Use of Androgen Deprivation Therapy in Prostate Cancer Management

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Use of Androgen Deprivation Therapy in Prostate Cancer: Indications and Prevalence

Asian Journal of Andrology
MedicineUrology
2012English

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer

Journal of Oncology Practice
Health PolicyOncology
2018English

Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy